Liu, Jiacong
Wu, Ziheng
Zhou, Shihong
Lv, Wang
Wang, Yiqing
Xia, Pinghui
Zhu, Linhai
Hu, Jian
Funding for this research was provided by:
National Key Research and Development Program of China (2022YFC2407303)
Research Center for Lung Tumor Diagnosis and Treatment of Zhejiang Province (JBZX-202007)
Article History
Received: 4 December 2024
Accepted: 15 April 2025
First Online: 29 April 2025
Declarations
:
: This trial was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (2024 IIT No. 0012), and done in accordance with the Declaration of Helsinki (as revised in 2013) and Good Clinical Practice Guidelines. Written informed consent was obtained from patients so that we could acquire and use required information from their medical record in our hospital.
: The authors declare no competing interests.